Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

4465results about "Eye surgery" patented technology

Intraocular physiological sensor

An implantable intraocular physiological sensor for measuring intraocular pressure, glucose concentration in the aqueous humor, and other physiological characteristics. The implantable intraocular physiological sensor may be at least partially powered by a fuel cell, such as an electrochemical glucose fuel cell. The implantable intraocular physiological sensor may wirelessly transmit measurements to an external device. In addition, the implantable intraocular physiological sensor may incorporate aqueous drainage and / or drug delivery features.
Owner:GLAUKOS CORP

Resonant converter tuning for maintaining substantially constant phaco handpiece power under increased load

ActiveUS6997935B2Simple filterReduced transistor switching loss lossEye surgerySurgeryPhacoemulsificationTransducer
A phacoemulsification system includes a phacoemulsification handpiece including a cutting tip ultrasonically vibrated by an ultrasonic transducer. A power supply is provided for driving the ultrasonic transducer at a resonant frequency of the transducer and cutting tip and varying power to the transducer, in response to loading of the cutting tip, by phase shifting drive signals to the resonant converter which supplies power to the transducer.
Owner:JOHNSON & JOHNSON SURGICAL VISION INC

Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof

A method and device for treating a mammalian organism to obtain a desired local or systemic physiological or pharmacological effect is provided. The method includes administering a sustained release drug delivery system to a mammalian organism in need of such treatment at an area wherein release of an effective agent is desired and allowing the effective agent to pass through the device in a controlled manner. The device includes an inner core or reservoir including the effective agent, an impermeable tube which encloses portions of the reservoir, and a permeable member at an end of the tube.
Owner:EYEPOINT PHARMA INC

Precision surgical system

A high-speed surgical handpiece (10) suitable for vitreoretinal surgery having a cutter (42) and actuators (36). The cutter (42) is a guillotine-type cutter activated by an array of leveraged piezoelectric actuators (30) that receive a driving signal from a driving controller. The controller can have control and display units with a plurality of input mechanisms receiving input from a user who selects a desired cutting rate and frequency for the cutter. The control unit produces a piezoelectric actuator output signal based on the inputs received. Fast cutting rates with reduced duty cycle as well as a proportional mode of operation are available, allowing slow controlled cutting action, for example proportional to depression of a foot-pedal (74). Low degrees of vibration and noise generation are produced.
Owner:DR ZACHARIAS JAIME

Automatic surgical device and control assembly for cutting a cornea

A surgical device for cutting substantially across a cornea of an eye of a patient, the device including a positioning ring to be attached to an eye surrounding a cornea to be cut, and defining an aperture sized to receive and expose the cornea to be cut. The surgical device further includes a cutting head assembly structured to be guided and driven over an upper surface of the positioning ring in a generally arcuate path, and having a cutting element positioned therein and structured to oscillate laterally to facilitate smooth and effective cutting of the cornea. The cutting head assembly is structured to be detachably coupled to the positioning ring by a coupling member which permits movement of the cutting head assembly relative to the positioning ring along the generally arcuate path, but maintains sufficient engagement therebetween to ensure that smooth, steady, driven movement is maintained.
Owner:HELLENKAMP JOHANN F

Phacoemulsification needle

InactiveUS7204820B2Shorten the timeRemove both the cataract nucleus and the residual cortexEye surgerySurgeryPhacoemulsificationResidual Tissues
The phacoemulsification needle according to the invention comprises a shaft, a tip disposed at a distal end of said shaft, the tip having a larger outer diameter than said shaft and an aspiration lumen extending through said shaft and said tip. The tip has an opening communicating with said aspiration lumen, a ball-shaped surface and a flat distal end comprising said opening. This needle can be used for removal of the cataract nucleus as well as for removal of the residual tissue.
Owner:ART LTD

Implantable ocular pump to reduce intraocular pressure

A trabecular pump is implantable in the eye to reduce intraocular pressure. The pump drains aqueous humor from the anterior chamber into outflow pathways, such as Schlemm's canal. A feedback system includes the intraocular pump and a pressure sensor in communication with the pump, for regulating intraocular pressure.
Owner:GLAUKOS CORP

Uveoscleral shunt and methods for implanting same

Devices and methods for treating intraocular pressure are disclosed. The devices include shunts for draining aqueous humor from the anterior chamber to the uveoscleral outflow pathway, including the supraciliary space and the suprachoroidal space. The shunts are preferably implanted by ab interno procedures.
Owner:GLAUKOS CORP

Ocular implant and methods for making and using same

An ocular implant device that is insertable into either the anterior or posterior chamber of the eye to drain aqueous humor and / or to introduce medications. The implant can include a substantially cylindrical body with a channel member that regulates the flow rate of aqueous humor from the anterior chamber or introduces medications into the posterior chamber, and simultaneously minimizes the ingress of microorganisms into the eye.
Owner:BECTON DICKINSON & CO

Flexible electro-active lens

A lens including a flexible refractive optic having a fixed refractive index, an electro-active element embedded within the flexible refractive optic, wherein the electro-active element has an alterable refractive index, and a controller electrically connected to the electro-active element wherein when power is applied thereto the refractive index of the electro-active element is altered.
Owner:E VISION SMART OPTICS INC

Glaucoma implant with therapeutic agents

InactiveUS20040127843A1Convenient treatmentReduce and inhibit and slow effectEye surgeryWound drainsAqueous humorSchlemm's canal
Devices and methods are provided for the treatment of glaucoma. An ocular implant is adapted such that aqueous humor flows controllably from the anterior chamber of the eye to Schlemm's canal, bypassing the trabecular meshwork. The implant may utilize one or more bioactive agents effective in treating glaucoma or other pathology.
Owner:DOSE MEDICAL CORP

Device for use in the eye

A glaucoma filtration implant is constituted by a generally tubular body section having an oblong external diameter formed of a continuous convex curve. The device preferably has flow resistance structure provided by a portion of the internal lumen having a reduced diameter. The flow resistance structure may have a length of up to 5000 mum and a diameter in the range 15 to 50 mum, the diameter being selected so as to achieve a pressure drop along the flow resistance structure in the range 5 to 15 mm Hg. The internal conduit for liquid flow also may include a removable flow inhibitor, which can be removed after implantation by a laser, such as an ophthalmic YAG laser. The device is made of biocompatible materials.
Owner:UNIV COLLEGE LONDON INST OF OPHTHALMOLOGY +1

Pulsed vacuum and/or flow method and apparatus for tissue removal

A method of controlling a surgical cutting device, the device including a hollow needle with a port for tissue entry and a moveable cutting blade for severing tissue entering the needle through the port, the blade being movable between a first portion enabling tissue entry through the port and a second portion closing the port, the tissue entering the needle being severed as the blade moves between the first and second portions, the method includes the steps: a) providing vacuum to the hollow needle to cause tissue entry into the needle through the port; b) moving the blade from the first portion to the second position to sever the tissue entering the needle; c) evacuating severed tissue from the needle by vacuum; d) reducing vacuum to the needle before moving the blade from the second position to the first position; and repeating steps (a) through (d).
Owner:JOHNSON & JOHNSON SURGICAL VISION INC

Implants for treating ocular hypertension, methods of use and methods of fabrication

A stent for treating ocular hypertension by providing means for enhancing outflows of aqueous humor from the anterior chamber. An exemplary stent is fabricated of a shape memory polymer (SMP) that can withstand very large reversible inelastic strains for storing energy in a temporary reduced cross-sectional shape. In one embodiment, the stent in a temporary shape is introduced into a targeted tissue volume in and about the eye's aqueous outflow pathways. Following minimally invasive implantation of the stent, body temperature or another stimulus causes the stent to move from its temporary shape to its memory shape thereby releasing stored energy to retract the tissue to open flow pathways or increase tissue permeability. In another embodiment, the SMP stent body has interior flow passageways to provide addition fluid outflow means. In several embodiments, the stent can be of a shape memory alloy material.
Owner:SHADDUCK JOHN H

Apparatus and method for a global coordinate system for use in robotic surgery

ActiveUS20150335480A1Facilitating robotic surgeryDiagnostics using lightEye surgeryKinematicsEngineering
An apparatus and method for establishing a global coordinate system to facilitate robotic assisted surgery. The coordinate system may be established using a combination of the robotic data, i.e., kinematics, and optical coherence tomographic images generated by an overhead optical assembly and a tool-based sensor. Using these components, the system may generate a computer-registered three-dimensional model of the patient's eye. In some embodiments, the system may also generate a virtual boundary within the coordinate system to prevent inadvertent injury to the patient.
Owner:AURIS HEALTH INC

Expandable glaucoma implant and methods of use

Disclosed is an implant for use in an eye with glaucoma, the implant including an inlet section in fluid communication with an outlet section, the inlet section being sized and shaped to fit at least partially in the anterior chamber of the eye, and the outlet section being sized and shaped to fit at least partially in Schlemm's canal of the eye. The implant also includes an expandable substrate suitable for expansion in the eye to assist in retaining the implant in the eye.
Owner:GLAUKOS CORP

Injectable glaucoma implants with multiple openings

Intraocular stents and applicators are disclosed for treating glaucoma. The stents are configured to extend between the anterior chamber of the eye and Schlemm's canal for enhancing outflow of aqueous from the anterior chamber so as to reduce intraocular pressure. The stents can have features for anchoring the stent into Schlemm's canal as well as preventing the walls of Schlemm's canal from closing the outlet of the stents. The applicators can be steerable so as to make implantation easier. Additionally, the applicators can be configured to hold a plurality of stents so that multiple stents can be implanted through one incision without removing the applicator from the incision between serial implantations.
Owner:GLAUKOS CORP

Glaucoma treatment kit

A glaucoma treatment kit, containing intraocular stents and applicators, is disclosed. The stents are configured to extend between the anterior chamber and Schlemm's canal of the eye, for enhancing outflow of aqueous from the anterior chamber so as to reduce intraocular pressure.
Owner:GLAUKOS CORP

Injectable gel implant for glaucoma treatment

InactiveUS20050277864A1Inhibit and slow effectEffective treatmentEye surgeryFlow mixersAqueous humorSchlemm's canal
Methods and implants for treating glaucoma in an eye are described. The implant includes an inlet section configured to be positioned in the anterior chamber of the eye and an outlet section in fluid communication with the inlet section. The outlet section is configured to be positioned in Schlemm's canal of the eye. The implant comprises a hydrogel and is configured to conduct aqueous humor from the anterior chamber to Schlemm's canal.
Owner:GLAUKOS CORP

Method, apparatus and system for a water jet

A water jet instrument may be used for manually performing eye surgery such as, cataract, or perform micro-surgery (remove cartilage), or any emulsification technique. The water jet instrument may be manually controlled or controlled by a system with a robotic control. The water jet apparatus defines a jet cutting area that is based at least in part on a flow rate meter and a feedback loop.
Owner:AURIS HEALTH INC

Liquid jet for glaucoma treatment

Methods of treating glaucoma are described including treatment of an eye with a liquid jet. The liquid jet can be generated by a laser-induced liquid jet instrument which is inserted through an incision in an eye. A stent can also be used, the stent having an inflow portion that is in fluid communication with an outflow portion. The stent can be inserted into the eye and transported from the incision through the anterior chamber of the eye toward the trabecular meshwork of the eye. In some embodiments, the stent can be advanced through the anterior chamber of the eye and provide fluid communication between the anterior chamber and Schlemm's canal. The method includes infusing fluid into an aqueous cavity and increasing the pressure of the fluid within the aqueous cavity.
Owner:GLAUKOS CORP

Ophthalmology implants and methods of manufacture

The present disclosure provides an ophthalmology implant and methods for treating glaucoma or optic neural transmission deficiency, wherein at least a portion of the implant is made of or includes a nanometer-sized substance, such as nanotubes, nanofibers, sheets from nanotubes, nanowires, nanofibrous mesh and the like.
Owner:GLAUKOS CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products